These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17970583)

  • 1. A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicity.
    Volarevic M; Wu CH; Smolic R; Andorfer JH; Wu GY
    Bioconjug Chem; 2007; 18(6):1965-71. PubMed ID: 17970583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting specificity and pharmacokinetics of asialoorosomucoid, a specific ligand for asialglycoprotein receptor on hepatocyte.
    Yang DY; Ouyang CH; Lu FG; Liu XW; Huang LQ
    J Dig Dis; 2007 May; 8(2):89-95. PubMed ID: 17532821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rate of intracellular transport and diacytosis on cytotoxicity of hybrid toxins. Study with hybrids using hepatic asialoglycoprotein receptor-mediated endocytosis.
    Chang TM; Hossain A; Chang CH
    Biochim Biophys Acta; 1994 Oct; 1224(1):77-88. PubMed ID: 7948044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second messenger modulation of the asialoglycoprotein receptor.
    Stockert RJ; Morell AG
    J Biol Chem; 1990 Feb; 265(4):1841-6. PubMed ID: 2153666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the variables affecting toxicity of hybrid toxins. The effect of different target cell receptor distribution and toxin binding chain.
    Chang TM; Chang CH
    Biochim Biophys Acta; 1989 Oct; 1013(3):239-46. PubMed ID: 2804085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes.
    Kinberger GA; Prakash TP; Yu J; Vasquez G; Low A; Chappell A; Schmidt K; Murray HM; Gaus H; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3690-3. PubMed ID: 27268307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted transplantation of mitochondria to hepatocytes.
    Gupta N; Wu CH; Wu GY
    Hepat Med; 2016; 8():115-134. PubMed ID: 27942238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor.
    Schmidt K; Prakash TP; Donner AJ; Kinberger GA; Gaus HJ; Low A; Østergaard ME; Bell M; Swayze EE; Seth PP
    Nucleic Acids Res; 2017 Mar; 45(5):2294-2306. PubMed ID: 28158620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer.
    Fox IJ; Chowdhury NR; Gupta S; Kondapalli R; Schilsky ML; Stockert RJ; Chowdhury JR
    Hepatology; 1995 Mar; 21(3):837-46. PubMed ID: 7875682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes.
    Tanowitz M; Hettrick L; Revenko A; Kinberger GA; Prakash TP; Seth PP
    Nucleic Acids Res; 2017 Dec; 45(21):12388-12400. PubMed ID: 29069408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
    Simmons CF; Schwartz AL
    Mol Pharmacol; 1984 Nov; 26(3):509-19. PubMed ID: 6092900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
    D'Souza AA; Devarajan PV
    J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy.
    Buchanan JH; Stevens A; Sidhu J
    Eur J Cell Biol; 1987 Feb; 43(1):141-7. PubMed ID: 3569303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and metabodynamics of hepatocyte targeting vector molecules in vivo].
    Ouyang CH; Lu FG; Yang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):26-8. PubMed ID: 12934389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of asialoglycoprotein receptor in human testis.
    Sun P; Zheng J; She G; Wei X; Zhang X; Shi H; Zhou X
    Cell Tissue Res; 2013 Jun; 352(3):761-8. PubMed ID: 23604802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high G418-resistant neo(R) transgenic mouse and mouse embryonic fibroblast (MEF) feeder layers for cytotoxicity and gene targeting in vivo and in vitro.
    Aubrecht J; Goad ME; Czopik AK; Lerner CP; Johnson KA; Simpson EM; Schiestl RH
    Drug Chem Toxicol; 2011 Oct; 34(4):433-9. PubMed ID: 21740348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the phorbol ester-mediated redistribution of asialoglycoprotein receptor: selective effects on receptor recycling pathways in Hep G2 cells.
    Fallon RJ; Schwartz AL
    Mol Pharmacol; 1987 Sep; 32(3):348-55. PubMed ID: 3478583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis.
    Igdoura SA
    Curr Opin Lipidol; 2017 Apr; 28(2):209-212. PubMed ID: 28092276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
    Thapa B; Kumar P; Zeng H; Narain R
    Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hepatocyte-targeted conjugate capable of delivering biologically active colchicine in vitro.
    Plourde R; Phillips AT; Wu CH; Hays RM; Chowdhury J; Chowdhury N; Wu GY
    Bioconjug Chem; 1996; 7(1):131-7. PubMed ID: 8742001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.